206 related articles for article (PubMed ID: 22512886)
1. Fertility preservation in women with vasculitis: experiences from the FertiPROTEKT network.
Henes JC; Henes M; von Wolff M; Schmalzing M; Kötter I; Lawrenz B
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S53-6. PubMed ID: 22512886
[TBL] [Abstract][Full Text] [Related]
2. Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network.
Henes M; Henes JC; Neunhoeffer E; Von Wolff M; Schmalzing M; Kötter I; Lawrenz B
Lupus; 2012 Aug; 21(9):953-8. PubMed ID: 22438026
[TBL] [Abstract][Full Text] [Related]
3. The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease.
Harward LE; Mitchell K; Pieper C; Copland S; Criscione-Schreiber LG; Clowse ME
Lupus; 2013 Jan; 22(1):81-6. PubMed ID: 23263867
[TBL] [Abstract][Full Text] [Related]
4. Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women.
von Wolff M; Dittrich R; Liebenthron J; Nawroth F; Schüring AN; Bruckner T; Germeyer A
Reprod Biomed Online; 2015 Nov; 31(5):605-12. PubMed ID: 26380870
[TBL] [Abstract][Full Text] [Related]
5. Fertility counseling and preservation practices in youth with lupus and vasculitis undergoing gonadotoxic therapy.
Nahata L; Sivaraman V; Quinn GP
Fertil Steril; 2016 Nov; 106(6):1470-1474. PubMed ID: 27521770
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents.
Elizur SE; Chian RC; Pineau CA; Son WY; Holzer HE; Huang JY; Gidoni Y; Levin D; Demirtas E; Tan SL
Rheumatology (Oxford); 2008 Oct; 47(10):1506-9. PubMed ID: 18660508
[TBL] [Abstract][Full Text] [Related]
7. Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.
Koga T; Umeda M; Endo Y; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Murakami N; Kitajima M; Kawakami A
Int J Rheum Dis; 2018 Jun; 21(6):1287-1292. PubMed ID: 29879312
[TBL] [Abstract][Full Text] [Related]
8. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
9. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
[TBL] [Abstract][Full Text] [Related]
10. Combination of fertility preservation strategies in young women with recently diagnosed cancer.
Huser M; Zakova J; Smardova L; Crha I; Janku P; Hudecek R; Ventruba P
Eur J Gynaecol Oncol; 2012; 33(1):42-50. PubMed ID: 22439404
[TBL] [Abstract][Full Text] [Related]
11. In vitro maturation of human immature oocytes for fertility preservation.
Chian RC; Uzelac PS; Nargund G
Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
[TBL] [Abstract][Full Text] [Related]
12. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
[TBL] [Abstract][Full Text] [Related]
13. DuoStim: a new option for fertility preservation for a woman with Turner syndrome.
Ito A; Katagiri Y; Tamaki Y; Fukuda Y; Oji A; Morita M
Gynecol Endocrinol; 2020 Dec; 36(12):1144-1148. PubMed ID: 32945708
[TBL] [Abstract][Full Text] [Related]
14. Fertility preservation in young women undergoing breast cancer therapy.
Sonmezer M; Oktay K
Oncologist; 2006 May; 11(5):422-34. PubMed ID: 16720842
[TBL] [Abstract][Full Text] [Related]
15. Fertility conservation in breast cancer patients.
Lawrenz B; Henes M; Neunhoeffer E; Kraemer B; Fehm T
Womens Health (Lond); 2011 Mar; 7(2):203-12. PubMed ID: 21410346
[TBL] [Abstract][Full Text] [Related]
16. Introduction: Female fertility preservation: innovations and questions.
Frydman R; Grynberg M
Fertil Steril; 2016 Jan; 105(1):4-5. PubMed ID: 26612064
[TBL] [Abstract][Full Text] [Related]
17. Fertility preservation in >1,000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques.
Lawrenz B; Jauckus J; Kupka MS; Strowitzki T; von Wolff M
Arch Gynecol Obstet; 2011 Mar; 283(3):651-6. PubMed ID: 21120512
[TBL] [Abstract][Full Text] [Related]
18. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients.
Andersen CY; Kristensen SG; Greve T; Schmidt KT
Future Oncol; 2012 May; 8(5):595-608. PubMed ID: 22646773
[TBL] [Abstract][Full Text] [Related]
19. [Breast cancer and fertility: critical review, considerations and perspectives].
This P
Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
[TBL] [Abstract][Full Text] [Related]
20. [Fertility preservation in women of the childbearing age: Indications and strategies].
Bénard J; Calvo J; Comtet M; Benoit A; Sifer C; Grynberg M
J Gynecol Obstet Biol Reprod (Paris); 2016 May; 45(5):424-44. PubMed ID: 27021926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
